4NVO : Decoding Novo Nordisk's Options Activity: What's...
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...
Popular GLP-1 medications may have health benefits that extend beyond weight loss and blood sugar control, a new study finds
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have other untapped potentials to reduce health risks.
The race for the next Ozempic is on
Two recent disappointing clinical trials of highly-anticipated weight-loss drugs have made it clear that it is too early to ...
Armed robbery in Revesby14h
Research Probes Flu Resistance Development
An international project into flu immunity could help develop better medications and vaccines to prevent severe disease.Imperial researchers will ...
greenqueen14h
These Alternative Food Coloring Startups Set To Win Big With FDA’s Ban on Red Dye No. 3
The US FDA has banned Red Dye No. 3 after its link with cancer in rats, presenting an opportunity to alternative food ...
UBS Remains a Buy on Novo Nordisk (0QIU)
UBS analyst Jo Walton maintained a Buy rating on Novo Nordisk (0QIU – Research Report) today and set a price target of DKK750.00. The company’s ...
Nine top stock picks to prepare your portfolio for 2025
Health care, ride sharing, and the emerging world of YouTube entertainers are among industries leading investors have picked ...